X4 Pharmaceuticals (FRA:48Q) Accumulated Depreciation : €-1.54 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is X4 Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

X4 Pharmaceuticals's quarterly accumulated depreciation stayed the same from Sep. 2023 (€-1.49 Mil) to Dec. 2023 (€-1.49 Mil) but then increased from Dec. 2023 (€-1.49 Mil) to Mar. 2024 (€-1.54 Mil).

X4 Pharmaceuticals's annual accumulated depreciation increased from Dec. 2021 (€-0.64 Mil) to Dec. 2022 (€-1.16 Mil) and increased from Dec. 2022 (€-1.16 Mil) to Dec. 2023 (€-1.49 Mil).

X4 Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for X4 Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X4 Pharmaceuticals Accumulated Depreciation Chart

X4 Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.24

-0.23

-0.64

-1.16

-1.49

X4 Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-1.27	-1.37	-1.49	-1.49	-1.54

X4 Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

X4 Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of X4 Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

X4 Pharmaceuticals (FRA:48Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » X4 Pharmaceuticals Inc (FRA:48Q) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

XFOR:USA 48Q:Germany

Address

61 North Beacon Street, 4th Floor, Boston, MA, USA, 02134

Website

https://www.x4pharma.com

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream.

X4 Pharmaceuticals (FRA:48Q) Headlines

No Headlines